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Abstract
PSORS1 (psoriasis susceptibility gene 1) is a major susceptibility locus for psoriasis. Several fine-mapping studies have
highlighted a 300-kb candidate region of PSORS1 where multiple biologically plausible candidate genes were suggested.
The most recent study has indicated HLA-Cw6 as the primary PSORS1 risk allele within the candidate region in a Caucasian
population. In this study, a family-based association analysis of the PSORS1 locus was performed by analyzing 10
polymorphic microsatellite markers from the PSORS1 region as well as HLA-B, HLA-C and CDSN loci in 163 Chinese families of
psoriasis. Five marker loci show strong evidence (P,10
23), and one marker locus shows weak evidence (P=0.04) for
association. The haplotype cluster analysis showed that all the risk haplotypes are Cw6 positive and share a 369-kb region of
homologous marker alleles which carries all the risk alleles, including HLA-Cw6 and CDSN*TTC, identified in this study. The
recombinant haplotype analysis of the HLA-Cw6 and CDSN*TTC alleles in 228 Chinese families showed that the HLA-Cw6
2/
CDSN*TTC
+ recombinant haplotype is clearly not associated with risk for psoriasis (T:NT=29:57, p=0.0025) in a Chinese
population, suggesting that the CDSN*TTC allele itself does not confer risk without the presence of the HLA-Cw6 allele. The
further exclusion analysis of the non-risk HLA-Cw6
2/CDSN*TTC
+ recombinant haplotypes with common recombination
breakpoints has allowed us to refine the location of PSORS1 to a small candidate region. Finally, we performed a conditional
linkage analysis and showed that the HLA-Cw6 is a major risk allele but does not explain the full linkage evidence of the
PSORS1 locus in a Chinese population. By performing a series of family-based association analyses of haplotypes as well as
an exclusion analysis of recombinant haplotypes, we were able to refine the PSORS1 gene to a small critical region where
HLA-C is a strong candidate to be the PSORS1 susceptibility gene.
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Introduction
Psoriasis (OMIM*177900) is a common chronic inflammatory
skindisorder affecting approximately2–5%ofCaucasian population
[1] and 0.123% of the Chinese population [2]. It has long been
widely accepted that psoriasis is a complex disease involving multiple
genetic and environmental factors. Past genome-wide linkage
analyses have identified nine susceptibility loci (designated
PSORS1–9) and an additional 13 suggestive linkage loci for psoriasis.
Among them,the PSORS1locus on6p21.3 isa well-confirmed major
susceptibility locus for psoriasis, which accounts for about 30% to
50% of the genetic contribution to the disease [3,4,5].
Many fine-mapping studies have been performed to refine the
localization of the PSORS1 gene. By using HLA types as markers,
Schmitt-Egenolf et al [6,7] shown that familial psoriasis is associated
with the class I end of the EH57.1 haplotype. By performing a
linkage disequilibrium (LD) mapping in the Caucasian population,
Balendran et al [8] suggested a 285-kb critical region for PSORS1
between the makers tn821 and HLA-C. Oka et al [9] furthermapped
the PSORS1 gene to a 111 kb interval telomeric to HLA-C through
an association analysis in the Japanese population. Similarly, Orru et
al’s study also highlighted a 70-kb critical region around the CDSN
gene that is not recombinant with PSORS1 by identical-by-descent
(IBD) haplotyping analysis in a Sardinian population [10]. A 150-kb
region telometic to HLA-C was also shown to be associated with
psoriasis ina Jewish population [11]. More recently, Lench et al [12]
performed a SNP-based association analysis and found strong
association toa 46-kb interval telomeric toHLA-C inbothCaucasian
and Japanese populations. Helm et al [13] also performed a
comprehensive case/control and family-based association study
using SNPs and located the PSORS1 to a haplotype block harboring
HLA-C and distinct from CDSN and HCR. Nair et al [14] carried out
a comprehensive analysis of the MHC region and narrowed the
candidate interval for PSORS1 to a 224-kb region in an American
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totally consistent with each other, these fine-mapping studies
generally suggested a critical region of about 300 kb for PSORS1,
containing HLA-C and at least 10 other genes.
As the PSORS1 locus contains the major histocompatibility
complex (MHC) that is known to be involved in many autoimmune
disorders, MHC genes have been intensively evaluated as the
candidates for the PSORS1 susceptibility gene. HLA-Cw6 has long
been known to be associated with susceptibility to psoriasis [15]
and was suggested to be a marker allele in LD with the PSORS1
susceptibility allele because of the lack of its functional role in
psoriasis [16,17,18]. However, a recent study indicated that there
are distinct differential expression patterns of HLA-C in psoriasis
and eczema, suggesting a functional role of HLA-C in psoriasis-
related immune response rather than general inflammation [19].
In addition, several other genes within the PSORS1 locus,
including MICA [20], CDSN [21,22,23], HCR [24,25,26,27,28],
and PSORS1C3 [29,30], were shown to be expressed in skin cells
and are, therefore, plausible candidates for the PSORS1 gene.
Other genes like SEEK1 and SPR1 genes were also suggested as
the candidates for PSORS1 [31]. Through a systematic screening
of densely distributed SNPs within a 150-kb region around HLA-C
by family-based analysis, Veal et al [32] identified the strongest
association evidence at two SNPs (n. 7 and n. 9) that are located 4
and 7 kb centromeric to HLA-C, respectively. Using the haplotype
sharing statistic HSS, Foerster et al [33] suggested the localization
of PSORS1 to a small region telomeric of HLA-C and indicated that
an endogenous retroviral dUTPase should be considered a
candidate for the PSORS1 gene.
Identification of the PSORS1 susceptibility gene has been
difficult due to the existence of extensive LD and multiple
biologically plausible candidate genes within the PSORS1 region
[34]. Most of the genes within the 300-kb critical region of
PSORS1 have been shown to be strongly associated with psoriasis
[24,29,31,35,36]. However, the risk alleles of these genes are
inseparable from each other due to strong linkage disequilibrium
among them. Single marker and haplotype-based association
analyses have therefore not been able to determine the primary
susceptibility allele. Functional analysis of the known genes within
this critical region has also failed to shed light on this problem,
because many of these genes have been shown or suggested to be
involved in the development of skin tissue and/or the pathogenesis
of psoriasis. To overcome this difficulty, Elder and his colleagues
genetically dissected the PSORS1 locus by directly sequencing risk-
associated haplotypes and subsequently analyzing recombinant
haplotypes that can separate the risk-associated alleles of the
several genes [14]. They demonstrated that of the eleven genes
within the 300-kb critical region of PSORS1, only HLA-C and
CDSN carry nonsynonymous alleles (protein alleles) that are
unique to the risk haplotypes of the PSORS1 locus, making them
the more likely candidates to be the PSORS1 gene. By analyzing
the recombinant haplotypes that carry only either the HLA-C or
CDSN risk allele, they further demonstrated that HLA-C is more
likely to be the PSORS1 susceptibility gene than the CDSN gene.
In this study, we performed the first fine mapping analysis of the
PSORS1 locus in Chinese population. The PSORS1 locus was
confirmed in Chinese population by our previous genome-wide
scan analysis [37]. Our previous case-control study had also shown
association of certain class I and II MHC alleles with psoriasis [38].
However, no fine mapping analyses of PSORS1 have been done in
Chinese population. By performing both population- and family-
based association analysis of haplotypes as well as an exclusion
analysis of recombinant haplotypes, we were able to refine the
PSORS1 gene to a small critical region where HLA-C is a strong
candidate of the PSORS1 susceptibility gene.
Materials and Methods
Ascertainment
A total of 228 Han Chinese psoriasis families, including 61
families used in our previous genome-wide linkage study, as well as
additional 192 sporadic cases and 192 healthy controls were
recruited in this study. All samples were recruited from the
Dermatology Department at No. 1 Hospital of the Anhui Medical
University by using an ascertainment procedure described
previously [37]. The structure and clinical characteristics of all
the 228 pedigrees are summarized in Table 1 and Supplementary
Table 1. All the samples were recruited with informed content.
The study was approved by the Ethics Committee of Anhui
Medical University and conducted according to the Declaration of
Helsinki Principles.
Genotyping Analysis
10 microsatellite markers (D6S1660, D6S1691, M6S187,
C2_4_5, C2_4_4, C1_3_2, C1_2_6, M6S172, D6S273 and
D6S1645) were genotyped in 163 families as well as the 192
sporadic cases and 192 healthy controls. The primer information
of the 10 microsatellite markers was obtained from the UniSTS
Database (http://www.ncbi.nlm.nih.gov/). Marker order and
distances were obtained from the National Center for Biotech-
nology Information (NCBI) database (the build 36.2). HLA-B
antigen alleles were also genotyped in the same 163 pedigrees by
using DNA-based methods (PCR-SSP) described elsewhere [39].
HLA-C and CDSN were genotyped in the 163 families and
additional 65 affected sib pairs. HLA-C alleles were determined by
genotyping seven SNPs within HLA-C using the method developed
by Nair et al [14]. The seven SNPs are located in exons 2 and 3 of
the HLA-C gene at positions 213, 218, 341, 361, 387, 459, and 540
(NM_002117.4). HLA-Cw6 genotype can be definitely distin-
guished from all other alleles by testing the observed genotypes
for the seven HLA-C SNPs against those produced by all possible
combinations of alleles in the IMGT/HLA database [14]. The
Author Summary
Psoriasis is a common skin disease with strong genetic risk.
The analysis of psoriatic families with multiple affected
individuals has identified several genomic regions that are
linked (showing linkage evidence) to the development of
psoriasis. Of them, the region on 6p21.3 (PSORS1) is a well-
confirmed major risk locus. The identification of the
disease risk gene within the PSOR1 locus, however, has
been difficult, largely due to the fact that several genes
show evidence for association with the disease develop-
ment and the evidences are highly correlated and hard to
be separated from each other. In this study, we performed
a fine mapping study of the PSORS1 locus in Chinese
families with psoriasis. By analyzing recombinant haplo-
types that carry different risk-associated genetic variants
within different genes, we were able to separate the
genetic effects observed within multiple genes and
identify strong supporting evidence for HLA-C to be the
primary risk gene of the PSORS1 locus. We have further
demonstrated that the genetic variation within the HLA-C
gene does not explain the full linkage evidence at the
PSORS1 locus, suggesting that there might be other risk
genes and/or alleles within the region. Our findings have
improved our understanding about the genetic complexity
of the PSORS1 locus.
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possible outcome given the genotypes of that person and other
family members or if the only other choices involved HLA-C
haplotypes known to be very rare in the study population. The
CDSN*TTC allele (defined as CDSN*632T-1249T-1256C) was
determined by genotyping three SNPs within CDSN. The three
polymorphisms within CDSN gene are located at positions 632,
1249, and 1256 of the coding sequence (NM_001264).
Genomic DNA was extracted from peripheral blood leukocytes
by using standard procedures [40]. Microsatellite markers were
genotyped by using a procedure described previously [41]. Briefly,
PCR amplifications were performed in a thermocycler 9700TM
(Perkin Elmer, Foster City, CA) and PCR products were pooled
together and analyzed on an automated ABI Prism 3730 DNA
sequencer (Applied Biosystems, Foster City, CA, USA). Gene-
Mapper 4.0 software (Applied Biosystems) was used for determin-
ing the fragment sizes of alleles that were further reviewed by two
persons independently. All SNPs were genotyped by using the
Snap-Shot method of the Applied Biosystems. Pedstats [42] was
used to check for non-Mendelian inheritance of alleles and Hardy–
Weinberg equilibrium in controls. Unlikely genotypes were further
identified by using Merlin (version 1.0.1) [43] and corrected by
reviewing the raw genotyping results or re-genotyping if necessary.
Haplotype Clustering
9-marker haplotypes were constructed in the 163 families by
using the genotypes of 7 microsatellite markers as well as the bi-
allelic genotypes of HLA-Cw6 and the quadric-allelic (TTT, TTC,
TGC and CTC) genotypes of CDSN locus. The haplotype
construction was done by using Merlin. Phase ambiguities in the
most-likely Merlin haplotypes were then resolved by PHASE
(version 2.1.1) whenever the confidence of the phase call was at
least 99%. The 9-marker founder haplotypes from the 163 families
were then clustered by using an average-distance agglomerative
hierarchical method [18] and SPSS 11.5. For haplotypes to be
clustered, more than 90% alleles of the haplotypes were required
to be typed and of known phase. The criteria for assigning
haplotypes to a cluster are $80% homogeneity of marker alleles
and a minimum number of five founders. Rare haplotypes that are
different from a haplotype cluster by only a single repeat (addition
or deletion) were merged into the haplotype cluster. The
haplotypes that can not be clustered using the above criteria were
lumped into a single cluster. The genotypes for HLA-B antigen
alleles were assigned to the haplotype clusters by the inspection of
informative pedigrees.
Association Test
Single-marker case-control association analysis was performed
using the two-tailed chi-squared statistic to compare allele
frequency differences. Correction for multiple testing was done
by calculating the false discovery rate (FDR) using Benjamini and
Hochberg’s method [44]. The odds ratio (OR) was calculated by
262 contingency tables.
A family-based transmission/disequilibrium test (TDT) was
performed by using either single locus genotypes or the haplotype
clusters. For all the pedigrees with at least one heterozygous parent
where allele or haplotype transmission could be determined, a
single affected child was chosen randomly for performing the TDT
test. Inferred genotypes and haplotypes of founder individuals
without DNA samples were not used in the TDT test due to the
potential bias [45].
Family-based conditional association analysis was performed by
using the WHAP program version 2.09 [46]. Single trio was
randomlyselectedfromeachofthe163families.The7microsatellites
were treated as multi-allelic locus by using the –usat command. We
first evaluated the association of everymarker with diseasephenotype
after controlling for the genotypes of the surrounding loci and then
the omnibus association evidence within the region after dropping the
HLA-Cw6 or CDSN*TTC risk allele from the null model.
Recombination Breakpoints Mapping and Exclusion
Analysis
The haplotypes of the HLA-Cw6 and CDSN*TTC alleles were
constructed in the 228 families by using Merlin and the biallelic
genotypes (+/+, +/2 and 2/2) of the two loci. The recombinant
haplotypes that carry either the HLA-Cw6 or CDSN*TTC risk
allele were identified and tested for association with psoriasis in the
same 228 families. Subsequently, the recombination breakpoints of
the recombinant haplotypes were mapped in the 163 families
where 10 microsatellite markers (in addition to the Cw6 and
CDSN*TTC alleles) were genotyped. The recombination break-
points were mapped to the last marker on both sides of the CDSN
locus that bears a risk allele, to ensure that these recombinant
haplotypes fully retained the portion of the candidate interval
being tested for exclusion. TDT test was subsequently performed
on the recombinant haplotypes sharing the same breakpoints to
assess association between the different portions of the PSORS1
candidate region and psoriasis. Due to the low frequency of the
HLA-Cw6
+/CDSN*TTC
2 recombinant haplotypes, only the HLA-
Cw6
2/CDSN*TTC
+ recombinant haplotypes were used in the
analysis of identifying the maximum portion of the HLA-Cw6
+/
CDSN*TTC
+ risk haplotype that is retained by the non-risk HLA-
Cw6
2/CDSN*TTC
+ recombinant haplotypes.
Combined Linkage and Association Analysis
To evaluate the contribution of the HLA-Cw6 allele to the
linkage evidence observed at the PSORS1 locus, we performed the
Linkage and Association Modeling in Pedigrees (LAMP) analysis
[47] in the 163 families using 7 microsatellite markers surrounding
the maximum LOD score peak identified in our previous genome-
wide analysis as well as the HLA-C and CDSN loci. LAMP linkage
test, direct association test and indirect association test have been
performed to get the linkage signal and to assess whether there are
other variants that can explain the linkage signal.
Results
Single-Locus Association Analysis
To follow up the linkage evidence at the HLA region (PSORS1)
identified by our previous genome-wide analysis [37], we
Table 1. Details of Structures of all Pedigrees.
No. of affected
members
No. of nuclear families (2
gen) Generation Total
triads dyads Sibships 3 gen 4 gen
12 1 0 0 0 3
25 2 3 3 6 5 1 0 1 5 1
31 7 1 4 1 5 1 3 1 6 0
$42 0 0 1 1 1 1 4
total 73 48 80 25 2 228
Nuclear (2 generation) families are classified as either triads (affected child and
two collected parents), dyads (affected child and one collected parent), or
Sibships (affected child and one or more collected sibs, with or without
parents).
doi:10.1371/journal.pgen.1000038.t001
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microsatellite markers from the PSORS1 locus in 163 Chinese
pedigrees (including the 61 families used in our genome-wide
linkage analysis). As expected, the family-based TDT test revealed
strong supporting evidence for our initial linkage finding (Fig 1).
Of the 10 microsatellite markers analyzed, 5 markers (M6S187,
C2_4_5, C2_4_4, C1_3_2 and M6S172) show strong evidence for
association with psoriasis (TDT p,10
23), and one marker
(C1_2_6) yields weak evidence for association (p=0.0437). The
results from the family-based TDT test are consistent with the
results from the association analysis of the same 10 microsatellite
markers in 192 unrelated cases and 192 controls (Supplementary
Table 2), except at D6S273 locus where the association with
psoriasis is suggested by the case-control analysis but not
supported by the family-based analysis.
Association between the HLA-Cw6 and CDSN*TTC
+ alleles and
psoriasis was also investigated by TDT test in the same 163
families. The HLA-Cw6 allele was determined by genotyping the
seven coding SNPs that can uniquely define the HLA-Cw6 allele,
and the CDSN*TTC allele was determined by directly genotyping
the three relevant SNPs (see Methods and Materials). The seven
SNPs of the HLA-C locus yielded 9 haplotypes, and the three SNPs
of the CDSN gene yielded 4 haplotypes. The haplotypes of each
gene were tested for association with psoriasis by using TDT test,
and the result is summarized in Table 2. As expected, only the
haplotypes carrying either HLA-Cw6 (HLA-C haplotype 11) or
CDSN*TTC (CDSN haplotype 2) allele are positively associated
with psoriasis. Both alleles are strongly associated with psoriasis,
although HLA-Cw6 allele seems to be more strongly associated
with psoriasis than CDSN*TTC allele (85.6% vs. 73.9% transmis-
sion; 2.0610
219 vs. 1.7610
28 TDT p value) (Table 2).
Haplotype Association Analysis
We then performed a haplotype-based TDT analysis in the 163
families. The haplotypes were constructed using the genotypes of
the 7 microsatellite markers showing single-locus association
evidence as well as the HLA-B, HLA-Cw6, CDSN*TTC loci. After
removing 31 inferred haplotypes, only 699 founder haplotypes
from the 163 families were used in the following haplotype
clustering and TDT test.
As described in Materials and Methods, the 699 founder
haplotypes were grouped into 29 haplotype clusters where the last
cluster (cluster 29) holds all the haplotypes that can not be
clustered otherwise. All the haplotype clusters, except the cluster
29, were tested for association with psoriasis by using family-based
TDT test, and the results are summarized in Table 3. The family-
based association analysis of the haplotype clusters was also
performed by using FBAT test, and the results are very consistent
to the TDT results (data not shown). Of the 28 clusters tested, 4
haplotype clusters (cluster 4, 5, 6, and 7) are associated with risk.
The four risk haplotypes share a 369-kb region of homologous
marker alleles between HLA-B and M6S187 where the HLA-Cw6
and CDSN*TTC risk alleles as well as the risk-associated alleles of
the 5 microsatellite markers are all present on these four risk
haplotypes. The four risk haplotypes seem to be derived from two
known ancient risk haplotypes (HLA-Cw6-B57 and HLA-Cw6-B13)
[36], and the 369-kb interval is the minimum fragment of the
ancestral haplotypes retained by all four risk haplotypes. The
clusters 24 and 27 also show moderate evidence for protective
effect. However, because the moderate evidence becomes
insignificant after correction for multiple testing and the two
clusters do not show any allele sharing, the evidence for the cluster
24 and 27 is likely to be false positive.
Hence, the haplotype analysis determined a 369-kb critical region
for the PSORS1. However, due to the strong linkage disequilibrium
within this region, association evidences observed at the HLA-Cw6
and CDSN*TTC alleles as well as other 5 marker alleles are not
independent from each other, and the haplotype-based analysis can
notdiscriminatewhichallelesistheprimarycauseofassociationwith
psoriasis observed within the PSORS1 locus.
Recombinant Haplotype Analysis
To evaluate which of the risk alleles within the 369-kb critical
region is likely to be the primary cause of association, we employed
the strategy of recombinant haplotype analysis where different risk
allele or alleles are evaluated for association separately. First, we
Figure 1. Single-Marker Association Analysis in 163 Families.
doi:10.1371/journal.pgen.1000038.g001
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likely to be the primary PSORS1 risk allele, by analyzing the
recombinant haplotypes that have separated the HLA-Cw6 and
CDSN*TTC risk alleles in the 163 families as well as additional 65
affected sib pairs. After discarding 101 (10.2%) phase unknown
haplotypes, the 889 founder haplotypes of the HLA-Cw6 and
CDSN*TTC alleles from the 228 pedigrees were analyzed by TDT
test (Table 4). Of the 889 founder haplotypes, HLA-Cw6
+/
CDSN*TTC
+ and HLA-Cw6
2/CDSN*TTC
2 haplotypes are both
common with 32.6% and 52.6% frequency, respectively. As
expected, the HLA-Cw6
+/CDSN*TTC
+ haplotype is strongly associ-
ated with risk for psoriasis (T:NT=129:34, p=9.9610
214), whereas
the HLA-Cw6
2/CDSN*TTC
2 haplotype is clearly not associated
(T:NT=50:117, p=2.2610
27). The HLA-Cw6
2/CDSN*TTC
+
recombinant haplotype is also common (12.9%) and is surely not
associated with risk for psoriasis (T:NT=29:57, p=0.0025). The
HLA-Cw6
+/CDSN*TTC
2 recombinant haplotype is rare (1.8%) so
that its association with risk can not be determined (Table 4). This
result strongly indicates that the CDSN*TTC allele itself does not
confer any risk without the presence of the HLA-Cw6 allele and
further suggests that the PSORS1 gene is likely to be located within
the HLA-C side of the 369 critical region.
We also performed a conditional association analysis using the
WHAP program. A total of 90 trios were selected randomly from
the 163 families. As shown in the table 5, only HLA-Cw6 shows
significant association evidence (empirical p-value from 1000
permutations=9.9610
24) after controlling for the genotypes of
the surrounding loci (including the CDSN*TTC allele), whereas the
CDSN*TTC allele no long shows significant association evidence
after controlling for the genotypes of the surrounding loci
(including the HLA-Cw6 allele). Furthermore, the omnibus
association test of the region becomes insignificant after controlling
the effect of HLA-Cw6 alleles (p=0.14), whereas the same omnibus
association test remains significant after controlling the effect of
CDSN*TTC allele (p=0.03). Being consistent with the results from
the recombinant haplotype analysis, the conditional association
analysis provides further supporting evidence that HLA-C is more
likely than CDSN to be the candidate of the PSORS1 gene or the
PSORS1 gene is more likely to be located nearby HLA-C than
CDSN within the 369-kb critical region.
To further refine the location of the PSORS1 gene in Chinese
population, we then performed an exclusion analysis within the
369-kb critical region (between HLA-B and M6S187), as
demonstrated in Nair et al’s study [14]. We first mapped the
breakpoints of ancestral recombination between the HLA-Cw6 and
CDSN*TTC alleles in the 163 families. By analyzing the genotypes
of 7 markers (HLA-Cw6, CDSN*TTC and 5 microsatellite markers)
within the 369-kb region, 105 recombinant haplotypes between
HLA-Cw6 and CDSN*TTC loci were identified (among the 699
founder chromosomes) in the 163 families, including 7 HLA-
Cw6
+/CDSN*TTC
2 haplotypes and 98 HLA-Cw6
2/CDSN*TTC
+
haplotypes (Table 6). Of the observed 105 recombinant haplo-
types, 32 (30.5%) of the recombination breakpoints are mapped to
the 48-kb region between HLA-C and M6S172, and 67 (63.8%)
are mapped to the 92-kb region between M6S172 and C1_3_2.
Only 6 (5.7%) recombination breakpoints are mapped to the 7-kb
interval between C1_3_2 and CDSN. Hence, the recombination
events between HLA-C and CDSN loci appear to be unevenly
distributed and are largely limited to the 140-kb interval between
HLA-C and C1_3_2 in the Chinese population. We then
performed an exclusion analysis within the 369-kb critical region
by identifying the maximum portion of the HLA-Cw6
+/
Table 2. Association of Psoriasis with Alleles of HLA-C and CDSN.
Gene and Haplotype
Number Corresponding Allele(s)
a
Haplotype
Sequence
b Frequency
c T:NT (%T)
d TDT
e
HLA-C
1 *01(0201–04, 06–13), *02(05), *08(12), *12(0301–07, 09, 11–13,15), *14(0202),
and *16(01–0401, 08)
GCCTCCG 0.1142 12:34(26.1) 1.0610
23
2 *01(05), *02(0201–04, 06–16), *03(14), *05(01–14), *07(07, 16), *08(0101–14),
*12(0201–0203, 08, 14 and 16-18), *15(0201–17), *16(06–07), and *17(01–04)
GCCACCG 0.1399 35:45(43.8) 2.6610
21
3 *03(0201–13, 16, and 18–29) GCCACTG 0.1655 19:49(27.9) 3.0610
24
4 *0315 GCAACTG 0.007 0:2(0) 4.9610
21
5 *03(17), *14(0201, and 0203–07N, 08) GCCTCTG 0.0536 3:22(12.0) 1.0610
24
6 *04(010101–0104, 0401, 05, 08–10, 12–14, and 16–21) GAAAGTG 0.0326 1:14(6.7) 1.0610
23
11 *06(02–13) CCATCCG 0.3893 137:23(85.6) 2.0610
219
12 *07(0101–03, 05–06, 08–10, 13–15, and 17–30, 32N-39) GCAACCG 0.0909 10:28(26.3) 3.0610
23
13 *07(0401–0402 and 11–12) CCAACCC 0.007 2:2(50.0) 1.0
CDSN
1 TTT 0.1994 41:89(31.5) 2.0610
25
2 TTC 0.4662 116:41(73.9) 1.7610
28
4 TGC 0.1227 25:44(36.2) 2.2610
22
6 CTC 0.2117 49:57(46.2) 4.4610
21
aHLA-C allele designations follow the classification scheme of release 2.14.1 (Aug 2006) of the IMGT/HLA Sequence Database maintained by the HLA Informatics Group
of the Anthony Nolan Research Institute. CDSN allele designations follow the classification scheme of Romphruk et al[49].
bHaplotype for seven coding SNPs of HLA-C (mRNA positions 213, 218, 341, 361, 387, 459, and 540) and three missense polymorphisms of CDSN (mRNA positions632,
1249, and 1256), in 59R39 orientation.
cHaplotype frequency, based on 889 founder chromosomes genotyped in 228 pedigrees for HLA-C and CDSN.
dFor the multi-allelic TDT.
eAll P values are uncorrected for multiple testing.
doi:10.1371/journal.pgen.1000038.t002
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+ risk haplotype that is retained by the non-risk HLA-
Cw6
2/CDSN*TTC
+ recombinant haplotypes. As shown in Table 7,
the HLA-Cw6
2/CDSN*TTC
+ recombinant haplotypes that carry
the C1_3_2-C2_4_5 portion of the HLA-Cw6
+/CDSN*TTC
+ risk
haplotype are clearly not associated with risk to psoriasis
(T:NT=28:47, p =0.028). It is also true for the HLA-Cw6
2/
CDSN*TTC
+ recombinant haplotypes that carry the C1_2_6-
C2_4_5 portion of the HLA-Cw6
+/CDSN*TTC
+ risk haplotype
(T:NT=27:45, p =0.034). For the HLA-Cw6
2/CDSN*TTC
+
recombinant haplotypes that carry the M6S172-CDSN portion
of the HLA-Cw6
+/CDSN*TTC
+ risk haplotype, our data suggested
an under-transmission of the recombinant haplotypes
(T:NT=11:20, p=0.11), but the evidence is not statistically
significant. Therefore, our results provided significant evidence for
supporting the exclusion of the C1_2_6-C2_4_5 interval from the
369-kb critical region of the PSORS1 locus. Our result also
provides suggestive evidence to further exclude the M6172-
C1_2_6 interval, but statistical evidence for this exclusion is
moderate and needs to be confirmed by further study.
Combined Linkage and Association Analysis of the HLA-
Cw6 Allele
Finally, we evaluated the contribution of the HLA-Cw6 risk allele
tothe linkage evidenceobserved atthe PSORS1 locus.Weperformed
a LAMP analysis in the 163 families by using the HLA-Cw6 and
CDSN*TTC alleles as well as the 7 microsatellite markers. As
expected, the LAMP analysis revealed highly significant evidences
for both linkage (LOD=5.19, p=2.6610
25) and association
(LOD=45.88, p=7.2610
248), and both the evidences are mapped
to the HLA-Cw6 locus. After controlling for the effect of the HLA-
Table 3. 10-Marker Haplotype Clusters and Family-Based Test of Association with Psoriasis.
cluster
a Frequency
b Alleles TDT
D6S273 HLA-B HLA-C M6S172 C1_2_6 C1_3_2 CDSN C2_4_4 C2_4_5 M6S187 T:NT(%T)
c P
d
7 0.009 4 13 2 1 1 2 TTC 2 3 1 9:1(90.0) 1.1610
22
4 0.065 2 57 2 1 1 2 TTC 2 3 1 42:7(85.7) 5.7610
27
5 0.028 2 13 2 1 1 2 TTC 2 3 3 21:4(84.0) 7.0610
24
6 0.018 3 13 2 1 4 2 TTC 2 3 3 9:2(81.8) 3.5610
22
11 0.01 5 13 2 1 1 2T T C 2337 : 2 (77.8) 9.6610
22
25 0.016 2 15 1 1 1 2 TTC 2 3 1 10:3(76.9) 5.2610
22
19 0.019 2 13 1 2 1 4 T T T 2111 1 : 5 (68.8) 1.3610
21
30 . 0 1 3 11 3 2 112T T C 231 8:4(66.7) 2.5610
21
10 0.019 3 13 2 1 6 2T T C 2331 0 : 7 (58.8) 4.7610
21
20 0.015 5 13 1 2 1 4 TTT 2 1 3 10:7(58.8) 4.7610
21
10 . 0 6 8 31 3 2 112T T C 2333 8 : 2 8 ( 5 7 . 6 ) 2 . 2 610
21
20 . 0 3 4 31 3 2 112T T C 2322 3 : 1 7 ( 5 7 . 5 ) 3 . 4 610
21
18 0.013 3 13 1 1 1 2 TTC 2 3 3 6:5(54.5) 7.6610
21
80 . 0 1 8 31 3 2 152T T C 233 10:10(50.0) 1
2 3 0 . 0 0 8 61 3 1 442T G T 2344 : 4 (50.0) 1
14 0.019 2 15 1 4 4 2 TGT 2 3 4 11:13(45.8) 6.8610
21
17 0.019 2 57 1 2 1 2 TTC 2 3 5 12:15(44.4) 5.6610
21
16 0.009 5 58 1 3 1 3 TGT 8 3 2 6:8(42.9) 5.9610
21
90 . 0 0 5 31 3 2 112T T C 2313 : 4 (42.9) 7.1610
21
28 0.008 3 27 1 2 7 4T T T 2123 : 4 (42.9) 7.1610
21
15 0.015 1 13 1 2 1 2 TTC 2 3 5 8:12(40.0) 3.7610
21
13 0.017 4 15 1 2 1 2 TTC 2 3 5 6:11(35.3) 2.3610
21
1 2 0 . 0 2 6 24 6 1 111T T T 3217 : 1 4 (33.3) 1.3610
21
26 0.007 2 35 1 1 5 6T G T 435 3:6(33.3) 3.2610
21
22 0.005 3 57 1 3 1 3 TGT 8 3 2 3:7(30.0) 2.1610
21
21 0.009 6 44 1 1 6 4T G C 6242 : 7 (22.2) 9.6610
22
2 4 0 . 0 1 21 3 1 215T G T 3221 : 7 (12.5) 3.4610
22
2 7 0 . 0 0 4 26 7 1 442T T C 2310 : 4 ( 0 ) 4 . 6 610
22
NOTE—The table displays all 9 markers subjected to haplotype clustering, along with HLA-B, in centromericRtelomeric order, from left to right. Italicized numbers
indicate that the allele occurred in 50%–80% of the founder haplotypes comprising the cluster. Numbers in roman type indicate that the allele occurred in at least 80%
of the founder haplotypes comprising the cluster. The alleles for HLA-B and CDSN are standard allele designations, whereas for HLA-C, 2 correspond to Cw6 alleles, and
1 corresponds to non-Cw6 alleles. The bold number area shows the minimum region of conserved by all risk haplotypes.
aAll clusters among 699 founder chromosomes genotyped in 163 pedigrees are shown.
bFrequency of haplotypes in cluster.
cFor the biallelic TDT.
dUncorrected exact binomial P value for TDT.
doi:10.1371/journal.pgen.1000038.t003
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significant (LOD=2.25, p=0.005). This suggests that the Cw6 allele
is a major contributor to the linkage evidence observed at the
PSORS1 locus, but it cannot explain the full linkage evidence.
Discussion
We have done the first fine mapping analysis of the PSORS1
locus in Chinese population. Our single-locus association analysis
provides strong supporting evidence for the PSORS1 locus in a
Chinese population and reveals a similar association pattern across
the PSORS1 region to that demonstrated in various populations.
Our haplotype-based association analysis indicates that all the risk
haplotypes within the PSORS1 locus are HLA-Cw6 positive and
likely derived from two known ancient risk haplotypes (HLA-Cw6-
B57 and HLA-Cw6-B13) in the Chinese population, consistent with
what has been found by previous studies in other populations. The
HLA-Cw7-B58 haplotype, which was found to be positively
associated with psoriasis in a Sardinian population [10], was not
present in the Chinese population. B13-Cw1 and B13-Cw3
haplotypes are present in our Chinese samples, but the sample
size of these two haplotypes was too small to test for association
with psoriasis. Allele comparison among all the risk haplotypes has
identified a 369-kb critical region for PSORS1 where all the risk-
associated alleles of the 5 marker loci as well as HLA-C and CDSN
loci are carried by the identified risk haplotypes, reflecting the
extensive LD across the PSORS1 region in the Chinese population
as reported in other populations. The 369-kb critical region
identified in Chinese population is very similar to the 300-kb
critical region identified in a western population by similar
methods [14].
Within the critical region, HLA-C and CDSN are the two leading
candidates for the PSORS1 gene both with strong supporting
evidence. HLA-Cw6 allele is the most significant marker for
psoriasis risk prediction and has been indicated to be involved in
the psoriasis-related immune response [19]. CDSN is the second
extensively investigated candidate and codes corneodesmosin
involved in keratinocyte cohesion and desquamation [48]. To
evaluate which of the two genes is more likely to be the candidate,
we performed the association analysis of the recombinant
haplotypes that carry only one of the two risk alleles of the two
genes. The frequencies of these two risk alleles in Chinese
population are 39% and 47%, respectively, which are slightly
higher than their frequencies in Caucasian population (21% and
23%, respectively) [14]. The frequency of the recombinant
haplotypes of the HLA-Cw6 and CDSN*TTC alleles is also higher
in Chinese psoriatic families (14.7%) than in Caucasian psoriatic
families (2.7%) [14]. The majority of the recombinant haplotypes
are HLA-Cw6
2/CDSN*TTC
+ haplotypes (12.9%) that are clearly
not associated with disease phenotype, suggesting that without the
HLA-Cw6 allele, CDSN*TTC does not confer any risk. This result
is further supported by our conditional association analysis where
only the HLA-Cw6 allele shows independent effect from the
genotypes of the surrounding marker loci including the
CDSN*TTC allele. Therefore, our results have clearly excluded
CDSN as the PSORS1 susceptibility gene, which is consistent with
the conclusion from Nair et al’s study in Caucasian population
[14].
We then attempted to further narrow down the location of the
PSORS1 gene within the 369-kb critical region by mapping the
recombination breakpoints and performing an exclusion analysis,
as illustrated in Nair et al’s study [14]. The common region of the
recombination breakpoints between HLA-C and CDSN loci in
Chinese population (HLA-C to C1_3_2) is only partially over-
lapped with the one observed in Caucasian population (M6S169
to CDSN) where over 90% of recombination breakpoints were
mapped [14]. In Caucasian population, most of the recombination
breakpoints between HLA-C and CDSN loci are located within the
region telomeric to C1_2_6 (M6S111) (89.5%), whereas in
Chinese population, most of the recombination breakpoints are
located within the region centromic to C1_2_6 (about 86.7%).
Our results can exclude the C1_2_6-C2_4_5 interval from the
369-kb critical region of PSORS1 with confidence. For the HLA-
Cw6
2/CDSN*TTC
+ recombinant haplotypes that carry the
M6S172-C2_4_5 portion of the HLA-Cw6
+/CDSN*TTC
+ risk
haplotype, our result also indicates an under-transmission of the
haplotypes (T:NT=11:20, p=0.11), but the evidence is not
statistically significant. Therefore, we can narrow down the
PSORS1 locus to the 172-kb region between HLA-B and C1_2_6
and potentially to the interval between HLA-B and M6S172, if the
exclusion of the M6S172-C2_4_5 interval can be confirmed by
further study in Chinese population. The more centromeric
location of the recombination breakpoints in Chinese population
(than in Caucasian population) allows us to narrow down the
location of the PSORS1 gene into a smaller region than Nair et al’s
study [14].
Within our conservatively mapped critical region of the PSORS1
between HLA-B and C1_2_6, there are only two known genes
HLA-C and HCG27. It has been confirmed by many studies,
including our present study, that the HLA-Cw6 allele is a strong
Table 4. Association of Psoriasis with Recombination
Haplotypes of HLA-Cw6 and CDSN*TTC Alleles.
haplotype Frequency
a TDT
T:NT (%T)
b P
c
HLA-Cw6
+/CDSN*TTC
+ 0.3262 129:34(79.1) 9.9610
214
HLA-Cw6
+/CDSN*TTC
2 0.0180 5:4(55.6) 7.4610
21
HLA-Cw6
2/CDSN*TTC
+ 0.1294 29:57(33.7) 2.5610
23
HLA-Cw6
2/CDSN*TTC
2 0.5264 50:117(29.9) 2.2610
27
aFrequency of founder haplotypes are based on 889 chromosomes genotyped
in 228 pedigrees.
bFor the biallelic TDT.
cUncorrected exact binomial P value for TDT.
doi:10.1371/journal.pgen.1000038.t004
Table 5. Results of Conditional Association Analysis.
locus
Single marker
analysis
Omnibus test
excluding
everything else
Omnibus test
after controlling
for locus
D6S273 1.9610
21 0.79 –
HLA-C 1.9610
23 9.9610
24 0.14
M6S172 2.9610
22 0.08 –
C1_2_6 3.1610
22 0.36 –
C1_3_2 1.9610
23 0.95 –
CDSN 3.9610
23 0.23 0.03
C2_4_4 3.9610
23 0.39 –
C2_4_5 7.4610
22 0.08 –
M6S187 4.3610
21 0.39 –
Empirical p-value from 1000 permutations were provided.
doi:10.1371/journal.pgen.1000038.t005
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HCG27 to be the primary susceptibility gene for psoriasis. Direct
sequence analysis of two risk haplotypes and eight non-risk
haplotypes by Nair et al [14] in Caucasian population indicated
that HCG27 carried no alleles unique to the risk haplotypes.
Besides these two known genes, there are a few ESTs as well as a
few conserved non-coding sequences within the critical region.
However, there is no supporting evidence for them to be
functional as either coding or regulatory sequences. Searching in
the UCSC Genome Browser (May 2006 version) also failed to
identify any evidence of known microRNAs within this critical
region. Therefore, our recombination mapping analysis has
provided strong supporting evidence for HLA-C to be the primary
susceptibility gene of the PSORS1 locus.
HLA-Cw6 is a major contributor to the linkage and association
evidence observed at the PSORS1 locus, but may not be the only
risk allele within the PSORS1 locus. The importance of the HLA-
Cw6 allele is demonstrated by the fact that after controlling for the
effect of the HLA-Cw6 allele, we could no longer identify
significant association evidence at the PSORS1 locus by the
family-based test, and the supporting evidence for linkage to the
PSORS1 locus has also been dramatically reduced. However, the
HLA-Cw6 allele cannot fully explain all the linkage evidence,
because the linkage evidence for the PSORS1 locus is still
significant after controlling for the effect of the HLA-Cw6 allele.
This result can be explained by two possibilities. The HLA-Cw6 is
not the only risk allele, and there are additional risk allele(s) within
the region. Alternatively, the HLA-Cw6 is only a marker allele and
therefore indirectly associated with disease phenotype through LD
with an unidentified causal allele. Although we can detect residual
linkage evidence after controlling the effect of the HLA-Cw6 allele,
we could not identify independent association evidence from the
HLA-Cw6 allele in our family-based association study. This could
be because our conditional family-based association analysis does
not have sufficient power for detecting the residual association
evidence due to the moderate number of informative families for
family-based association test. It is very interesting to see that the
HLA-Cw6 can only partially explain the observed linkage evidence
at the PSORS1 locus, but the result needs to be confirmed by more
studies.
Our fine mapping result is only partially consistent with the ones
from previous studies. The minimal candidate region of PSORS1
mapped by our study overlaps the regions mapped in an American
Caucasian population [14] and a Jewish population [11], but is
different from the ones mapped by other studies in Caucasian,
Japanese and Sardinian psoriatic populations [9,10,12] (Fig 2).
This difference could be due to the existence of different risk
haplotypes in other populations. For example, The HLA-Cw7-B58
recombinant was found to be positively associated with psoriasis in
Sardinian samples but not present in our Chinese samples. The
Table 6. 105
a Recombinant Haplotypes between the Risk Alleles of HLA-Cw6 and CDSN*TTC.
Haplotype Type cluster Alleles
c
HLA-B HLA-C M6S172 C1_2_6 C1_3_2 CDSN C2_4_4 C2_4_5 Number
Cw6+/CDSN*TTC+
b 1 13/57 2 1 1/4 2 TTC 2 3
Cw6+/CDSN*TTC- 1 1 3 21 12---1
2 13/57 2 1 1/4 ----2
3- 21 -----2
4 13 2 - -----2
Cw6-/CDSN*TTC+ 1 - -- --TTC 2 3 3
2- - - - 2 TTC 2 3 7
3- - - 1/4 2 TTC 2 3 52
4- - 1 1/4 2 TTC 2 3 29
5 - -- --TTC --2
6- - - - 2 TTC 2 -1
7- - - 4 2 TTC 2 -3
8- - 1 1 2 TTC 2 -1
aOf the 699 founder chromosomes from 163 pedigrees.
bShow all the risk alleles within the 369-kb critical region carried by all the Cw6+/CDSN*TTC+ risk haplotypes
cBold alleles are the risk alleles within the 369-kb critical region of the Cw6+/CDSN*TTC+ risk haplotypes that are carried by the recombinant haplotypes; and ‘-’ indicates
non-risk alleles.
doi:10.1371/journal.pgen.1000038.t006
Table 7. Association Analysis of the HLA-Cw6
2/CDSN*TTC
+
Recombinant Haplotypes Carrying Different Portions of the
HLA-Cw6
+/CDSN*TTC
+ Risk Haplotype.
Test region
a number Frequency
b TDT
T:NT (%T)
c chi p
d
CDSN-C2_4_5 91 0.1302 28:49(36.4) 5.7 1.7610
22
C1_3_2-C2_4_5 88 0.1259 28:47(37.3) 4.8 2.8610
22
C1_2_6-C2_4_5 81 0.1159 27:45(37.5) 4.5 3.4610
22
M6S172-C2_4_5 29 0.0415 11:20(35.5) 2.6 1.1610
21
aTo be conservative, the smallest possible portion of the extended risk
haplotype carried by HLA-Cw6
2/CDSN*TTC
+_recombinant haplotypes were
used to determine whether a recombinant haplotype qualified for assessing
the exclusion of the test region from the PSORS1 candidate interval.
bFrequency of HLA-Cw6
2/CDSN*TTC
+ recombinants carrying the test region;
results are based on 699 founder chromosomes in 163 pedigrees.
cFor the biallelic TDT.
dUncorrected exact binomial P value for TDT.
doi:10.1371/journal.pgen.1000038.t007
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methodologies for fine mapping analysis. Another explanation is
that there might be different susceptibility alleles in different
populations. Giving the fact that psoriasis is a chronic inflamma-
tory skin disorder and that many genes within the PSORS1 region
are known to be involved in autoimmune response and skin
development, it is not implausible that there might be more than
one gene within this region to play a role in the pathogenesis of
psoriasis. It is therefore possible that different ethnic populations
might carry different susceptibility alleles from different genes and
that the results from the fine mapping studies done in different
populations are not always consistent with each other due to the
genetic heterogeneity of the PSORS1 locus. Further studies will be
needed to confirm this hypothesis.
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